{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:10:09Z","timestamp":1787069409166,"version":"build-2736575974"},"reference-count":168,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000005","name":"US Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.nbd.2026.107336","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T07:48:49Z","timestamp":1772178529000},"page":"107336","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Voltage-gating and neuronal signalling in neurodegeneration: From neuropathology to therapeutic opportunities in motor neuron disease"],"prefix":"10.1016","volume":"221","author":[{"given":"Charan","family":"Kotapati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Van","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda C.","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2026.107336_bb0005","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s00415-021-10670-y","article-title":"Randomized phase 2 study of perampanel for sporadic amyotrophic lateral sclerosis","volume":"269","author":"Aizawa","year":"2022","journal-title":"J. Neurol."},{"key":"10.1016\/j.nbd.2026.107336_bb0010","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2017.00269","article-title":"Smn-deficiency increases the intrinsic excitability of motoneurons","volume":"11","author":"Arumugam","year":"2017","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.nbd.2026.107336_bb0015","first-page":"22","article-title":"New drug approved for ALS","volume":"123","author":"Aschenbrenner","year":"2023","journal-title":"Am. J. Nurs."},{"key":"10.1016\/j.nbd.2026.107336_bb0020","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3988\/jcn.2013.9.2.65","article-title":"The puzzling case of hyperexcitability in amyotrophic lateral sclerosis","volume":"9","author":"Bae","year":"2013","journal-title":"J. Clin. Neurol."},{"key":"10.1016\/j.nbd.2026.107336_bb0025","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1113\/jphysiol.2010.191965","article-title":"Mechanisms of closed-state inactivation in voltage-gated ion channels","volume":"589","author":"Bahring","year":"2011","journal-title":"J. Physiol."},{"key":"10.1016\/j.nbd.2026.107336_bb0030","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.4103\/0972-2327.74250","article-title":"Motor neuron disease and frontotemporal dementia: one, two, or three diseases?","volume":"13","author":"Bak","year":"2010","journal-title":"Ann. Indian Acad. Neurol."},{"key":"10.1016\/j.nbd.2026.107336_bb0035","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1755-5949.2009.00116.x","article-title":"A review of the neural mechanisms of action and clinical efficiency of riluzole in treating amyotrophic lateral sclerosis: what have we learned in the last decade?","volume":"17","author":"Bellingham","year":"2011","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.nbd.2026.107336_bb0040","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13054-019-2718-9","article-title":"Brainstem dysfunction in critically ill patients","volume":"24","author":"Benghanem","year":"2020","journal-title":"Crit. Care"},{"key":"10.1016\/j.nbd.2026.107336_bb0045","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1056\/NEJM199403033300901","article-title":"A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS\/Riluzole study group","volume":"330","author":"Bensimon","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.nbd.2026.107336_bb0050","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/mus.28287","article-title":"A 40-week phase 2B randomized, multicenter, double-blind, placebo-controlled study evaluating the safety and efficacy of memantine in amyotrophic lateral sclerosis","volume":"71","author":"Bhai","year":"2025","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nbd.2026.107336_bb0055","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1038\/s41598-019-57314-w","article-title":"Shorter axon initial segments do not cause repetitive firing impairments in the adult presymptomatic G127X SOD-1 amyotrophic lateral sclerosis mouse","volume":"10","author":"Bonnevie","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2026.107336_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11102622","article-title":"ClC-1 Chloride Channel: inputs on the structure-function relationship of Myotonia Congenita-causing mutations","volume":"11","author":"Brenes","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.nbd.2026.107336_bb0065","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s00415-018-8968-7","article-title":"Kennedy's disease (spinal and bulbar muscular atrophy): a clinically oriented review of a rare disease","volume":"266","author":"Breza","year":"2019","journal-title":"J. Neurol."},{"key":"10.1016\/j.nbd.2026.107336_bb0070","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.neuroscience.2004.03.051","article-title":"Association of potassium channel Kv3.4 subunits with pre- and post-synaptic structures in brainstem and spinal cord","volume":"126","author":"Brooke","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2026.107336_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101590","article-title":"Intravenous edaravone treatment in ALS and survival: an exploratory, retrospective, administrative claims analysis","volume":"52","author":"Brooks","year":"2022","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.nbd.2026.107336_bb0080","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.700103","article-title":"Palliative care challenges of patients with progressive bulbar palsy: a retrospective case series of 14 patients","volume":"12","author":"Bublitz","year":"2021","journal-title":"Front. Neurol."},{"key":"10.1016\/j.nbd.2026.107336_bb0085","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1093\/hmg\/ddz107","article-title":"Altered calcium dynamics and glutamate receptor properties in iPSC-derived motor neurons from ALS patients with C9orf72, FUS, SOD1 or TDP43 mutations","volume":"28","author":"Bursch","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2026.107336_bb0090","doi-asserted-by":"crossref","first-page":"5616","DOI":"10.1073\/pnas.090034797","article-title":"Sodium channel Na(v)1.6 is localized at nodes of ranvier, dendrites, and synapses","volume":"97","author":"Caldwell","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.nbd.2026.107336_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114107","article-title":"Multi-targeting sodium and calcium channels using venom peptides for the treatment of complex ion channels-related diseases","volume":"181","author":"Cardoso","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.nbd.2026.107336_bb0100","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1111\/bph.13962","article-title":"Sodium channels and pain: from toxins to therapies","volume":"175","author":"Cardoso","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.nbd.2026.107336_bb0105","doi-asserted-by":"crossref","first-page":"366","DOI":"10.3389\/fphar.2019.00366","article-title":"Structure-function and therapeutic potential of spider venom-derived cysteine knot peptides targeting sodium channels","volume":"10","author":"Cardoso","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.nbd.2026.107336_bb0110","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1124\/mol.115.098178","article-title":"Identification and characterization of ProTx-III [\u03bc-TRTX-Tp1a], a new voltage-gated sodium channel inhibitor from venom of the tarantula Thrixopelma pruriens","volume":"88","author":"Cardoso","year":"2015","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.nbd.2026.107336_bb0115","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/SPC.0000000000000335","article-title":"Toxins in pain","volume":"12","author":"Cardoso","year":"2018","journal-title":"Curr. Opin. Support. Palliat. Care"},{"key":"10.1016\/j.nbd.2026.107336_bb0120","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/j.pain.0000000000002041","article-title":"A spider-venom peptide with multitarget activity on sodium and calcium channels alleviates chronic visceral pain in a model of irritable bowel syndrome","volume":"162","author":"Cardoso","year":"2021","journal-title":"Pain"},{"key":"10.1016\/j.nbd.2026.107336_bb0125","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.924023","article-title":"Editorial: venom peptides: a rich combinatorial library for drug development","volume":"9","author":"Cardoso","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.nbd.2026.107336_bb0130","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1146\/annurev.bi.64.070195.002425","article-title":"Structure and function of voltage-gated ion channels","volume":"64","author":"Catterall","year":"1995","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.nbd.2026.107336_bb0135","doi-asserted-by":"crossref","first-page":"2281714","DOI":"10.1080\/19336950.2023.2281714","article-title":"Voltage gated sodium and calcium channels: discovery, structure, function, and pharmacology","volume":"17","author":"Catterall","year":"2023","journal-title":"Channels"},{"key":"10.1016\/j.nbd.2026.107336_bb0140","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.nbd.2016.04.009","article-title":"Voltage-gated calcium channels are abnormal in cultured spinal motoneurons in the G93A-SOD1 transgenic mouse model of ALS","volume":"93","author":"Chang","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2026.107336_bb0145","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1113\/jphysiol.2014.281428","article-title":"Na+ channel function, regulation, structure, trafficking and sequestration","volume":"593","author":"Chen-Izu","year":"2015","journal-title":"J. Physiol."},{"key":"10.1016\/j.nbd.2026.107336_bb0150","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/0002-9149(82)90348-4","article-title":"Development and design of specific inhibitors of angiotensin-converting enzyme","volume":"49","author":"Cushman","year":"1982","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.nbd.2026.107336_bb0155","doi-asserted-by":"crossref","first-page":"456","DOI":"10.3109\/17482968.2010.498521","article-title":"A randomized, placebo-controlled trial of memantine for functional disability in amyotrophic lateral sclerosis","volume":"11","author":"de Carvalho","year":"2010","journal-title":"Amyotroph. Lateral Scler."},{"key":"10.1016\/j.nbd.2026.107336_bb0160","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.neuron.2011.09.011","article-title":"Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS","volume":"72","author":"DeJesus-Hernandez","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2026.107336_bb0165","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0301-2115(00)00311-0","article-title":"History and use of oxytocics","volume":"94","author":"den Hertog","year":"2001","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.nbd.2026.107336_bb0170","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2012.00017","article-title":"Molecular insights into the local anesthetic receptor within voltage-gated sodium channels using hydroxylated analogs of Mexiletine","volume":"3","author":"Desaphy","year":"2012","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.nbd.2026.107336_bb0175","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1523\/JNEUROSCI.4512-03.2004","article-title":"KCNQ2 is a nodal K+ channel","volume":"24","author":"Devaux","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2026.107336_bb0180","doi-asserted-by":"crossref","first-page":"5999","DOI":"10.1038\/ncomms6999","article-title":"Human iPSC-derived motoneurons harbouring TARDBP or C9ORF72 ALS mutations are dysfunctional despite maintaining viability","volume":"6","author":"Devlin","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.nbd.2026.107336_bb0185","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s40478-025-01934-z","article-title":"TDP-43 pathology is sufficient to drive axon initial segment plasticity and hyperexcitability of spinal motoneurones in vivo in the TDP43-DeltaNLS model of amyotrophic lateral sclerosis","volume":"13","author":"Djukic","year":"2025","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.nbd.2026.107336_bb0190","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/ana.10374","article-title":"Cyclooxygenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALS","volume":"52","author":"Drachman","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2026.107336_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113085","article-title":"Persistent NaV1.1 and NaV1.6 currents drive spinal locomotor functions through nonlinear dynamics","volume":"42","author":"Drouillas","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.nbd.2026.107336_bb0200","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.mcn.2008.06.008","article-title":"Nav1.1 is predominantly expressed in nodes of Ranvier and axon initial segments","volume":"39","author":"Duflocq","year":"2008","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.nbd.2026.107336_bb0205","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1111\/jnc.15214","article-title":"Mislocalisation of TDP-43 to the cytoplasm causes cortical hyperexcitability and reduced excitatory neurotransmission in the motor cortex","volume":"157","author":"Dyer","year":"2021","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2026.107336_bb0210","doi-asserted-by":"crossref","unstructured":"Eisen, A., et al., 1993. Anti-glutamate therapy in amyotrophic lateral sclerosis: a trial using lamotrigine. Can. J. Neurol. Sci. 20, 297\u2013301.","DOI":"10.1017\/S0317167100048204"},{"key":"10.1016\/j.nbd.2026.107336_bb0215","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci11030300","article-title":"The dying forward hypothesis of ALS: tracing its history","volume":"11","author":"Eisen","year":"2021","journal-title":"Brain Sci."},{"key":"10.1016\/j.nbd.2026.107336_bb0220","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1523\/JNEUROSCI.2024-16.2017","article-title":"Target cell type-dependent differences in ca(2+) channel function underlie distinct release probabilities at hippocampal glutamatergic terminals","volume":"37","author":"Eltes","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2026.107336_bb0225","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S1474-4422(18)30054-1","article-title":"Stage at which riluzole treatment prolongs survival in patients with amyotrophic lateral sclerosis: a retrospective analysis of data from a dose-ranging study","volume":"17","author":"Fang","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2026.107336_bb0230","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1002\/acn3.51648","article-title":"Effects of PB-TURSO on the transcriptional and metabolic landscape of sporadic ALS fibroblasts","volume":"9","author":"Fels","year":"2022","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.nbd.2026.107336_bb0235","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1021\/bi00815a005","article-title":"Isolation of bradykinin-potentiating peptides from Bothrops jararaca venom","volume":"9","author":"Ferreira","year":"1970","journal-title":"Biochemistry"},{"key":"10.1016\/j.nbd.2026.107336_bb0240","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa1702752","article-title":"Nusinersen versus sham control in infantile-onset spinal muscular atrophy","volume":"377","author":"Finkel","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.nbd.2026.107336_bb0245","doi-asserted-by":"crossref","DOI":"10.1038\/srep39662","article-title":"Insensitivity to pain induced by a potent selective closed-state Nav1.7 inhibitor","volume":"7","author":"Flinspach","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2026.107336_bb0250","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1212\/01.wnl.0000341933.97883.a4","article-title":"Transcranial magnetic stimulation in ALS: utility of central motor conduction tests","volume":"72","author":"Floyd","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2026.107336_bb0255","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.amjmed.2018.07.012","article-title":"Motor neuron disease: pathophysiology, diagnosis, and management","volume":"132","author":"Foster","year":"2019","journal-title":"Am. J. Med."},{"key":"10.1016\/j.nbd.2026.107336_bb0260","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.105696","article-title":"Differential roles of Na(V)1.2 and Na(V)1.6 in neocortical pyramidal cell excitability","volume":"14","author":"Garcia","year":"2025","journal-title":"Elife"},{"key":"10.1016\/j.nbd.2026.107336_bb0265","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.neuroscience.2016.10.048","article-title":"Electrophysiological characterization of the M-current in rat hypoglossal motoneurons","volume":"340","author":"Ghezzi","year":"2017","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2026.107336_bb0270","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1113\/JP275906","article-title":"Functional up-regulation of the M-current by retigabine contrasts hyperexcitability and excitotoxicity on rat hypoglossal motoneurons","volume":"596","author":"Ghezzi","year":"2018","journal-title":"J. Physiol."},{"key":"10.1016\/j.nbd.2026.107336_bb0275","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1007\/s11064-009-9983-y","article-title":"Modulation of glutamate and glycine transporters by niflumic, flufenamic and mefenamic acids","volume":"34","author":"Habjan","year":"2009","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.nbd.2026.107336_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113509","article-title":"Aberrant axon initial segment plasticity and intrinsic excitability of ALS hiPSC motor neurons","volume":"42","author":"Harley","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.nbd.2026.107336_bb0285","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1083\/jcb.123.4.949","article-title":"Identification and differential subcellular localization of the neuronal class C and class D L-type calcium channel alpha 1 subunits","volume":"123","author":"Hell","year":"1993","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.nbd.2026.107336_bb0290","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-52539-4","article-title":"Structural basis for the rescue of hyperexcitable cells by the amyotrophic lateral sclerosis drug Riluzole","volume":"15","author":"Hollingworth","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.nbd.2026.107336_bb0295","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/nn.2359","article-title":"Distinct contributions of Na(v)1.6 and Na(v)1.2 in action potential initiation and backpropagation","volume":"12","author":"Hu","year":"2009","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2026.107336_bb0300","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.742457","article-title":"Engineering of a spider peptide via conserved structure-function traits optimizes Sodium Channel inhibition in vitro and anti-nociception in vivo","volume":"8","author":"Hu","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.nbd.2026.107336_bb0305","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1073\/pnas.0511197103","article-title":"Voltage-gated ion channels in the axon initial segment of human cortical pyramidal cells and their relationship with chandelier cells","volume":"103","author":"Inda","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.nbd.2026.107336_bb0310","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158596","article-title":"Axonal dysfunction precedes motor neuronal death in amyotrophic lateral sclerosis","volume":"11","author":"Iwai","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2026.107336_bb0315","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2113813119","article-title":"Poly-dipeptides produced from C9orf72 hexanucleotide repeats cause selective motor neuron hyperexcitability in ALS","volume":"119","author":"Jo","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.nbd.2026.107336_bb0320","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.neuroscience.2020.11.016","article-title":"Increased axon initial segment length results in increased Na(+) currents in spinal Motoneurones at symptom onset in the G127X SOD1 mouse model of amyotrophic lateral sclerosis","volume":"468","author":"Jorgensen","year":"2021","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2026.107336_bb0325","doi-asserted-by":"crossref","first-page":"364","DOI":"10.3109\/17482960903513159","article-title":"The clinical course of progressive bulbar palsy","volume":"11","author":"Karam","year":"2010","journal-title":"Amyotroph. Lateral Scler."},{"key":"10.1016\/j.nbd.2026.107336_bb0330","doi-asserted-by":"crossref","first-page":"E7184","DOI":"10.1073\/pnas.1720493115","article-title":"Role of sodium channel subtype in action potential generation by neocortical pyramidal neurons","volume":"115","author":"Katz","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.nbd.2026.107336_bb0335","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s10787-011-0116-2","article-title":"NSAIDs in the treatment and\/or prevention of neurological disorders","volume":"20","author":"Khansari","year":"2012","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.nbd.2026.107336_bb0340","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1212\/WNL.0b013e3181c1dea3","article-title":"Study of 962 patients indicates progressive muscular atrophy is a form of ALS","volume":"73","author":"Kim","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2026.107336_bb0345","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.neuron.2007.07.031","article-title":"Axon initial segment Kv1 channels control axonal action potential waveform and synaptic efficacy","volume":"55","author":"Kole","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2026.107336_bb0350","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s10867-016-9411-x","article-title":"Mutant SOD1 protein increases NaV1.3 channel excitability","volume":"42","author":"Kubat Oktem","year":"2016","journal-title":"J. Biol. Phys."},{"key":"10.1016\/j.nbd.2026.107336_bb0355","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1113\/jphysiol.2004.074138","article-title":"Increased persistent Na(+) current and its effect on excitability in motoneurones cultured from mutant SOD1 mice","volume":"563","author":"Kuo","year":"2005","journal-title":"J. Physiol."},{"key":"10.1016\/j.nbd.2026.107336_bb0360","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/352077a0","article-title":"Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy","volume":"352","author":"La Spada","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2026.107336_bb0365","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.70144","article-title":"Pleiotropic effects of the NSAID fenamates on chloride channels: opportunity for ion channelopathies?","volume":"13","author":"Laghetti","year":"2025","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.nbd.2026.107336_bb0370","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1056\/NEJM199601253340408","article-title":"Octreotide","volume":"334","author":"Lamberts","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.nbd.2026.107336_bb0375","first-page":"276","article-title":"Frontotemporal dementia with a C9ORF72 expansion in a Swedish family: clinical and neuropathological characteristics","volume":"2","author":"Landqvist Waldo","year":"2013","journal-title":"Am. J. Neurodegener. Dis."},{"key":"10.1016\/j.nbd.2026.107336_bb0380","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1152\/jn.1999.81.1.140","article-title":"Voltage-activated K+ currents of hypoglossal motoneurons in a brain stem slice preparation from the neonatal rat","volume":"81","author":"Lape","year":"1999","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.nbd.2026.107336_bb0385","first-page":"1","article-title":"Glutamate pathway implication in amyotrophic lateral sclerosis: what is the signal in the noise?","volume":"4","author":"Le Verche","year":"2011","journal-title":"J. Recept. Ligand Channel Res."},{"key":"10.1016\/j.nbd.2026.107336_bb0390","doi-asserted-by":"crossref","first-page":"iv32","DOI":"10.1136\/jnnp.74.suppl_4.iv32","article-title":"The management of motor neurone disease","volume":"74","author":"Leigh","year":"2003","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.nbd.2026.107336_bb0395","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.4103\/1673-5374.165308","article-title":"Is hyperexcitability really guilty in amyotrophic lateral sclerosis?","volume":"10","author":"Leroy","year":"2015","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.nbd.2026.107336_bb0400","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.ncl.2015.07.005","article-title":"Progressive muscular atrophy","volume":"33","author":"Liewluck","year":"2015","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.nbd.2026.107336_bb0405","article-title":"A comprehensive review on ziconotide","volume":"10","author":"Lin","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.nbd.2026.107336_bb0410","doi-asserted-by":"crossref","first-page":"3764","DOI":"10.1523\/JNEUROSCI.2843-20.2021","article-title":"Functional microstructure of CaV-mediated calcium signaling in the axon initial segment","volume":"41","author":"Lipkin","year":"2021","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2026.107336_bb0415","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0028-3908(02)00400-8","article-title":"Differential interactions of lamotrigine and related drugs with transmembrane segment IVS6 of voltage-gated sodium channels","volume":"44","author":"Liu","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2026.107336_bb0420","article-title":"Spinal muscular atrophy patient-derived motor neurons exhibit hyperexcitability","volume":"5","author":"Liu","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2026.107336_bb0425","doi-asserted-by":"crossref","DOI":"10.1007\/s00415-025-13130-z","article-title":"Global burden of motor neuron disease: unraveling socioeconomic disparities, aging dynamics, and divergent future trajectories (1990-2040)","volume":"272","author":"Liu","year":"2025","journal-title":"J. Neurol."},{"key":"10.1016\/j.nbd.2026.107336_bb0430","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1016\/S0140-6736(08)60921-6","article-title":"Spinal muscular atrophy","volume":"371","author":"Lunn","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.nbd.2026.107336_bb0435","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1080\/21678421.2020.1790607","article-title":"TDP-43 pathology in primary lateral sclerosis","volume":"21","author":"Mackenzie","year":"2020","journal-title":"Amyotroph. Lateral Scler. Frontotemporal Degener."},{"key":"10.1016\/j.nbd.2026.107336_bb0440","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S1474-4422(12)70043-1","article-title":"Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study","volume":"11","author":"Majounie","year":"2012","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2026.107336_bb0445","doi-asserted-by":"crossref","first-page":"8692","DOI":"10.1016\/S0021-9258(18)81848-8","article-title":"Anticoagulant activity of synthetic hirudin peptides","volume":"264","author":"Maraganore","year":"1989","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2026.107336_bb0450","doi-asserted-by":"crossref","first-page":"5207","DOI":"10.1073\/pnas.91.11.5207","article-title":"Calcium transients in dendrites of neocortical neurons evoked by single subthreshold excitatory postsynaptic potentials via low-voltage-activated calcium channels","volume":"91","author":"Markram","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.nbd.2026.107336_bb0455","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1055\/s-2002-35292","article-title":"Hirudin as alternative anticoagulant--a historical review","volume":"28","author":"Markwardt","year":"2002","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.nbd.2026.107336_bb0460","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1111\/ene.14393","article-title":"Amyotrophic lateral sclerosis: a clinical review","volume":"27","author":"Masrori","year":"2020","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.nbd.2026.107336_bb0465","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1007\/s00429-021-02315-7","article-title":"Transmitter and ion channel profiles of neurons in the primate abducens and trochlear nuclei","volume":"226","author":"Mayadali","year":"2021","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.nbd.2026.107336_bb0470","doi-asserted-by":"crossref","DOI":"10.3389\/fnana.2024.1411154","article-title":"Ion channel profiles of extraocular motoneurons and internuclear neurons in human abducens and trochlear nuclei","volume":"18","author":"Mayadali","year":"2024","journal-title":"Front. Neuroanat."},{"key":"10.1016\/j.nbd.2026.107336_bb0475","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1706198","article-title":"Single-dose gene-replacement therapy for spinal muscular atrophy","volume":"377","author":"Mendell","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.nbd.2026.107336_bb0480","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/ene.13295","article-title":"Cortical hyperexcitability and disease spread in amyotrophic lateral sclerosis","volume":"24","author":"Menon","year":"2017","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.nbd.2026.107336_bb0485","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0960-8966(95)00024-0","article-title":"Controlled trial of nimodipine in amyotrophic lateral sclerosis","volume":"6","author":"Miller","year":"1996","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.nbd.2026.107336_bb0490","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/mus.880190405","article-title":"A clinical trial of verapamil in amyotrophic lateral sclerosis","volume":"19","author":"Miller","year":"1996","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nbd.2026.107336_bb0495","doi-asserted-by":"crossref","unstructured":"Miller, R. G., et al., 2012. Riluzole for amyotrophic lateral sclerosis (ALS)\/motor neuron disease (MND). Cochrane Database Syst. Rev. 2012, CD001447.","DOI":"10.1002\/14651858.CD001447.pub3"},{"key":"10.1016\/j.nbd.2026.107336_bb0500","doi-asserted-by":"crossref","DOI":"10.1212\/01.NXG.0000464294.88607.dd","article-title":"Phenotypic and molecular analyses of primary lateral sclerosis","volume":"1","author":"Mitsumoto","year":"2015","journal-title":"Neurol. Genet."},{"key":"10.1016\/j.nbd.2026.107336_bb0505","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.tips.2025.03.007","article-title":"Venom peptides regulating Ca2+ homeostasis: neuroprotective potential","volume":"46","author":"Muller","year":"2025","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.nbd.2026.107336_bb0510","first-page":"1","article-title":"Structure-function and pharmacologic aspects of ion channels relevant to neurologic channelopathies","volume":"203","author":"M\u04d3nnikk\u04e7","year":"2024","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.nbd.2026.107336_bb0515","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/bmb\/ldp049","article-title":"Motor neuron disease: systematic reviews of treatment for ALS and SMA","volume":"93","author":"Orrell","year":"2010","journal-title":"Br. Med. Bull."},{"key":"10.1016\/j.nbd.2026.107336_bb0520","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1056\/NEJMoa1916945","article-title":"Trial of sodium phenylbutyrate-taurursodiol for amyotrophic lateral sclerosis","volume":"383","author":"Paganoni","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.nbd.2026.107336_bb0525","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1523\/JNEUROSCI.4314-05.2006","article-title":"A common ankyrin-G-based mechanism retains KCNQ and NaV channels at electrically active domains of the axon","volume":"26","author":"Pan","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2026.107336_bb0530","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1093\/brain\/awl104","article-title":"The first ALS2 missense mutation associated with JPLS reveals new aspects of alsin biological function","volume":"129","author":"Panzeri","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2026.107336_bb0535","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1016\/j.ebiom.2015.11.022","article-title":"Flecainide in amyotrophic lateral sclerosis as a neuroprotective strategy (FANS): a randomized placebo-controlled trial","volume":"2","author":"Park","year":"2015","journal-title":"EBioMedicine"},{"key":"10.1016\/j.nbd.2026.107336_bb0540","doi-asserted-by":"crossref","first-page":"266","DOI":"10.3109\/17482960903307805","article-title":"A phase II trial of talampanel in subjects with amyotrophic lateral sclerosis","volume":"11","author":"Pascuzzi","year":"2010","journal-title":"Amyotroph. Lateral Scler."},{"key":"10.1016\/j.nbd.2026.107336_bb0545","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.expneurol.2012.11.002","article-title":"Over-expression of N-type calcium channels in cortical neurons from a mouse model of amyotrophic lateral sclerosis","volume":"247","author":"Pieri","year":"2013","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2026.107336_bb0550","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1152\/jn.00241.2002","article-title":"Persistent sodium and calcium currents in rat hypoglossal motoneurons","volume":"89","author":"Powers","year":"2003","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.nbd.2026.107336_bb0555","article-title":"History of insulin","volume":"2","author":"Quianzon","year":"2012","journal-title":"J. Community Hosp. Intern. Med. Perspect."},{"key":"10.1016\/j.nbd.2026.107336_bb0560","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1113\/jphysiol.2010.200659","article-title":"Altered postnatal maturation of electrical properties in spinal motoneurons in a mouse model of amyotrophic lateral sclerosis","volume":"589","author":"Quinlan","year":"2011","journal-title":"J. Physiol."},{"key":"10.1016\/j.nbd.2026.107336_bb0565","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2015.00139","article-title":"Comparison of dendritic calcium transients in juvenile wild type and SOD1(G93A) mouse lumbar motoneurons","volume":"9","author":"Quinlan","year":"2015","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.nbd.2026.107336_bb0570","doi-asserted-by":"crossref","first-page":"4605","DOI":"10.1210\/en.2014-1385","article-title":"Diabetes insipidus: celebrating a century of vasopressin therapy","volume":"155","author":"Qureshi","year":"2014","journal-title":"Endocrinology"},{"key":"10.1016\/j.nbd.2026.107336_bb0575","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1113\/jphysiol.2004.065003","article-title":"State-dependent trapping of flecainide in the cardiac sodium channel","volume":"560","author":"Ramos","year":"2004","journal-title":"J. Physiol."},{"key":"10.1016\/j.nbd.2026.107336_bb0580","article-title":"Brain stimulation as a therapeutic tool in amyotrophic lateral slerosis: current status and interaction with mechanisms of altered cortical excitability","volume":"11","author":"Ranieri","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.nbd.2026.107336_bb0585","series-title":"Relyvrio as the treatment for patients with amyotrophic lateral sclerosis (ALS). \u0418\u0437\u0434\u0430\u0435\u0442\u0441\u044f \u043f\u043e \u0440\u0435\u0448\u0435\u043d\u0438\u044e \u0440\u0435\u0434\u0430\u043a\u0446\u0438\u043e\u043d\u043d\u043e-\u0438\u0437\u0434\u0430\u0442\u0435\u043b\u044c\u0441\u043a\u043e\u0433\u043e \u0441\u043e\u0432\u0435\u0442\u0430 \u0424\u0413\u0411\u041e\u0423 \u0412\u041e \u041a\u0413\u041c\u0423 \u041c\u0438\u043d\u0437\u0434\u0440\u0430\u0432\u0430 \u0420\u043e\u0441\u0441\u0438\u0438. 76","author":"Rashidan Shah","year":"2023"},{"key":"10.1016\/j.nbd.2026.107336_bb0590","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.jpainsymman.2005.10.003","article-title":"A randomized, double-blind, placebo-controlled study of intrathecal ziconotide in adults with severe chronic pain","volume":"31","author":"Rauck","year":"2006","journal-title":"J. Pain Symptom Manag."},{"key":"10.1016\/j.nbd.2026.107336_bb0595","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105673","article-title":"TDP-43 is a ubiquitylation substrate of the SCF(cyclin F) complex","volume":"167","author":"Rayner","year":"2022","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2026.107336_bb0600","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.neuron.2014.12.063","article-title":"From intrinsic firing properties to selective neuronal vulnerability in neurodegenerative diseases","volume":"85","author":"Roselli","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2026.107336_bb0605","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1113\/jphysiol.2002.037069","article-title":"A-, T-, and H-type currents shape intrinsic firing of developing rat abducens motoneurons","volume":"549","author":"Russier","year":"2003","journal-title":"J. Physiol."},{"key":"10.1016\/j.nbd.2026.107336_bb0610","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1034\/j.1600-0404.2003.00111.x","article-title":"A double-blind randomized clinical trial in amyotrophic lateral sclerosis using lamotrigine: effects on CSF glutamate, aspartate, branched-chain amino acid levels and clinical parameters","volume":"108","author":"Ryberg","year":"2003","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.nbd.2026.107336_bb0615","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104532","article-title":"Modified age-dependent expression of NaV1.6 in an ALS model correlates with motor cortex excitability alterations","volume":"130","author":"Saba","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2026.107336_bb0620","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2202-9-112","article-title":"The Kv2.1 K+ channel targets to the axon initial segment of hippocampal and cortical neurons in culture and in situ","volume":"9","author":"Sarmiere","year":"2008","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.nbd.2026.107336_bb0625","doi-asserted-by":"crossref","first-page":"9359","DOI":"10.1016\/S0021-9258(18)92826-7","article-title":"Barbourin. A GPIIb-IIIa-specific integrin antagonist from the venom of Sistrurus m. barbouri","volume":"266","author":"Scarborough","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2026.107336_bb0630","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1523\/JNEUROSCI.14-04-02408.1994","article-title":"Contrasting subcellular localization of the Kv1.2 K+ channel subunit in different neurons of rat brain","volume":"14","author":"Sheng","year":"1994","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2026.107336_bb0635","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.expneurol.2011.08.015","article-title":"Markedly reduced axonal potassium channel expression in human sporadic amyotrophic lateral sclerosis: an immunohistochemical study","volume":"232","author":"Shibuya","year":"2011","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2026.107336_bb0640","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1136\/jnnp-2020-324026","article-title":"Split hand and motor axonal hyperexcitability in spinal and bulbar muscular atrophy","volume":"91","author":"Shibuya","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.nbd.2026.107336_bb0645","article-title":"NaV1.7 mRNA and protein expression in putative projection neurons of the human spinal dorsal horn","author":"Shiers","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.nbd.2026.107336_bb0650","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/ana.410390210","article-title":"Ultrastructural evidence for altered calcium in motor nerve terminals in amyotropic lateral sclerosis","volume":"39","author":"Siklos","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2026.107336_bb0655","first-page":"3725","article-title":"Tauroursodeoxycholic acid enhances mitochondrial biogenesis, neural stem cell pool, and early neurogenesis in adult rats","volume":"55","author":"Soares","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.nbd.2026.107336_bb0660","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.ncl.2015.07.007","article-title":"Primary lateral sclerosis","volume":"33","author":"Statland","year":"2015","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.nbd.2026.107336_bb0665","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.1093\/hmg\/dds195","article-title":"Role of NaV1.9 in activity-dependent axon growth in motoneurons","volume":"21","author":"Subramanian","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2026.107336_bb0670","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1523\/JNEUROSCI.19-06-01895.1999","article-title":"Differential distribution of three members of a gene family encoding low voltage-activated (T-type) calcium channels","volume":"19","author":"Talley","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2026.107336_bb0675","first-page":"11","article-title":"Antihyperalgesic effects of ProTx-II, a Nav1.7 antagonist, and A803467, a Nav1.8 antagonist, in diabetic mice","volume":"7","author":"Tanaka","year":"2015","journal-title":"J. Exp. Pharmacol."},{"key":"10.1016\/j.nbd.2026.107336_bb0680","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2014.00297","article-title":"Molecular identity of axonal sodium channels in human cortical pyramidal cells","volume":"8","author":"Tian","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.nbd.2026.107336_bb0685","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/jnc.12738","article-title":"The voltage-gated calcium channel blocker lomerizine is neuroprotective in motor neurons expressing mutant SOD1, but not TDP-43","volume":"130","author":"Tran","year":"2014","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2026.107336_bb0690","doi-asserted-by":"crossref","unstructured":"Triplitt, C., Chiquette, E., 2006. Exenatide: from the Gila monster to the pharmacy. J. Am. Pharm. Assoc. 46, 44\u201352; (quiz 53-5).","DOI":"10.1331\/154434506775268698"},{"key":"10.1016\/j.nbd.2026.107336_bb0695","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S1474-4422(13)70036-X","article-title":"Controversies and priorities in amyotrophic lateral sclerosis","volume":"12","author":"Turner","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2026.107336_bb0700","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1136\/jnnp-2019-322541","article-title":"Primary lateral sclerosis: consensus diagnostic criteria","volume":"91","author":"Turner","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.nbd.2026.107336_bb0705","doi-asserted-by":"crossref","first-page":"5652","DOI":"10.1523\/JNEUROSCI.14-09-05652.1994","article-title":"Properties and function of low- and high-voltage-activated Ca2+ channels in hypoglossal motoneurons","volume":"14","author":"Umemiya","year":"1994","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2026.107336_bb0710","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1523\/JNEUROSCI.15-03-02218.1995","article-title":"Single-channel properties of four calcium channel types in rat motoneurons","volume":"15","author":"Umemiya","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2026.107336_bb0715","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0048983","article-title":"Genetic overlap between apparently sporadic motor neuron diseases","volume":"7","author":"van Blitterswijk","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2026.107336_bb0720","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.molmed.2023.12.003","article-title":"The sense of antisense therapies in ALS","volume":"30","author":"Van Daele","year":"2024","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.nbd.2026.107336_bb0725","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1212\/WNL.0b013e3182661d14","article-title":"Hexanucleotide repeat expansions in C9ORF72 in the spectrum of motor neuron diseases","volume":"79","author":"van Rheenen","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2026.107336_bb0730","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1111\/j.1460-9568.1995.tb00641.x","article-title":"Immunohistochemical localization of five members of the Kv1 channel subunits: contrasting subcellular locations and neuron-specific co-localizations in rat brain","volume":"7","author":"Veh","year":"1995","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2026.107336_bb0735","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2023.105992","article-title":"Early deficits in GABA inhibition parallels an increase in L-type Ca2+ currents in the jaw motor neurons of SOD1(G93A) mouse model for ALS","volume":"177","author":"Venugopal","year":"2023","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2026.107336_bb0740","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s13023-017-0671-8","article-title":"Prevalence, incidence and carrier frequency of 5q-linked spinal muscular atrophy - a literature review","volume":"12","author":"Verhaart","year":"2017","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.nbd.2026.107336_bb0745","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1152\/jn.1993.69.6.2137","article-title":"Calcium conductances and their role in the firing behavior of neonatal rat hypoglossal motoneurons","volume":"69","author":"Viana","year":"1993","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.nbd.2026.107336_bb0750","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1152\/jn.1993.69.6.2150","article-title":"Multiple potassium conductances and their role in action potential repolarization and repetitive firing behavior of neonatal rat hypoglossal motoneurons","volume":"69","author":"Viana","year":"1993","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.nbd.2026.107336_bb0755","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2025.107247","article-title":"Reduced cortico-muscular output is associated with intrinsic hypoexcitability and reduced persistent inward currents in motor cortex neurons of TDP-43(Q331K) ALS mice","volume":"218","author":"Viteri","year":"2026","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2026.107336_bb0760","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1093\/brain\/awl172","article-title":"Novel threshold tracking techniques suggest that cortical hyperexcitability is an early feature of motor neuron disease","volume":"129","author":"Vucic","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2026.107336_bb0765","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1093\/brain\/awn071","article-title":"Cortical hyperexcitability may precede the onset of familial amyotrophic lateral sclerosis","volume":"131","author":"Vucic","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2026.107336_bb0770","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.celrep.2014.03.019","article-title":"Intrinsic membrane hyperexcitability of amyotrophic lateral sclerosis patient-derived motor neurons","volume":"7","author":"Wainger","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.nbd.2026.107336_bb0775","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1001\/jamaneurol.2020.4300","article-title":"Effect of Ezogabine on cortical and spinal motor neuron excitability in amyotrophic lateral sclerosis: a randomized clinical trial","volume":"78","author":"Wainger","year":"2021","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.nbd.2026.107336_bb0780","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1527-3466.2008.00041.x","article-title":"The novel antioxidant edaravone: from bench to bedside","volume":"26","author":"Watanabe","year":"2008","journal-title":"Cardiovasc. Ther."},{"key":"10.1016\/j.nbd.2026.107336_bb0785","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1212\/WNL.0000000000002507","article-title":"A randomized trial of mexiletine in ALS: safety and effects on muscle cramps and progression","volume":"86","author":"Weiss","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2026.107336_bb0790","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/347281a0","article-title":"Clustering of L-type Ca2+ channels at the base of major dendrites in hippocampal pyramidal neurons","volume":"347","author":"Westenbroek","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2026.107336_bb0795","doi-asserted-by":"crossref","first-page":"6319","DOI":"10.1523\/JNEUROSCI.18-16-06319.1998","article-title":"Localization of Ca2+ channel subtypes on rat spinal motor neurons, interneurons, and nerve terminals","volume":"18","author":"Westenbroek","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2026.107336_bb0800","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.molcel.2020.10.039","article-title":"Structural basis for high-affinity trapping of the NaV1.7 channel in its resting state by tarantula toxin","volume":"81","author":"Wisedchaisri","year":"2021","journal-title":"Mol. Cell"},{"key":"10.1016\/j.nbd.2026.107336_bb0805","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1001\/jamaneurol.2021.4893","article-title":"Safety and effectiveness of long-term intravenous administration of edaravone for treatment of patients with amyotrophic lateral sclerosis","volume":"79","author":"Witzel","year":"2022","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.nbd.2026.107336_bb0810","first-page":"746","article-title":"Leuprolide: a gonadotropin-releasing hormone analog for the palliative treatment of prostatic cancer","volume":"20","author":"Wojciechowski","year":"1986","journal-title":"Drug Intell. Clin. Pharm."},{"key":"10.1016\/j.nbd.2026.107336_bb0815","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S1474-4422(17)30115-1","article-title":"Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial","volume":"16","author":"Writing","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2026.107336_bb0820","doi-asserted-by":"crossref","first-page":"5094","DOI":"10.1523\/JNEUROSCI.3485-15.2016","article-title":"Defects in neuromuscular transmission may underlie motor dysfunction in spinal and bulbar muscular atrophy","volume":"36","author":"Xu","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2026.107336_bb0825","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1167\/iovs.06-0943","article-title":"Sodium 4-phenylbutyrate acts as a chemical chaperone on misfolded myocilin to rescue cells from endoplasmic reticulum stress and apoptosis","volume":"48","author":"Yam","year":"2007","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.nbd.2026.107336_bb0830","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1172\/JCI28773.","article-title":"Androgen-dependent pathology demonstrates myopathic contribution to the Kennedy disease phenotype in a mouse knock-in model","volume":"116","author":"Yu","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.nbd.2026.107336_bb0835","doi-asserted-by":"crossref","first-page":"171","DOI":"10.4103\/2152-7806.169561","article-title":"A comprehensive review of amyotrophic lateral sclerosis","volume":"6","author":"Zarei","year":"2015","journal-title":"Surg. Neurol. Int."},{"key":"10.1016\/j.nbd.2026.107336_bb0840","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1113\/JP271207","article-title":"Stimulation-induced Ca2+ influx at nodes of Ranvier in mouse peripheral motor axons","volume":"594","author":"Zhang","year":"2016","journal-title":"J. Physiol."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096999612600080X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096999612600080X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T21:24:12Z","timestamp":1779485052000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096999612600080X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":168,"alternative-id":["S096999612600080X"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2026.107336","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Voltage-gating and neuronal signalling in neurodegeneration: From neuropathology to therapeutic opportunities in motor neuron disease","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2026.107336","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107336"}}